Pattern Scanning Laser (PASCAL) for Peripheral Iridoplasty in Eyes With Plateau Iris Syndrome: A Novel Application.
Midha Neha, Hoskens Kirsten, Mansouri Kaweh
AI Summary
PASCAL laser iridoplasty for plateau iris syndrome was studied. It safely widened angles and reduced IOP, suggesting a promising alternative to current treatments for this glaucoma type.
Abstract
Purpose
The purpose of this study was to evaluate safety and efficacy of pattern scanning laser (PASCAL) for peripheral iridoplasty in eyes with plateau iris syndrome.
Materials and methods
This study was a retrospective review of cases that underwent PASCAL laser peripheral iridoplasty. Eyes with plateau iris syndrome confirmed on gonioscopy and ultrasound biomicroscopy were included in the study. Primary and secondary outcome measures were angle widening on gonioscopy and magnitude of intraocular pressure (IOP) reduction, respectively.
Results
Twelve eyes of 8 patients that completed 1-year follow-up were analyzed. Angle widening was noted in 46% of treated quadrants by at least 1 grade (Shaffer classification) at 1-month follow-up. A statistically significant IOP reduction was noted at 1 year from 20.6±4.8 to 17.8±3.8 mm Hg (P=0.01). At 1 month, 8 of 12 eyes (66.6%) achieved gonioscopic success (widening of the angle by at least 1 grade in 2 of 4 quadrants). At 1 year, 6 of 12 eyes (50%) achieved tonometric success (20% reduction or 3 mm Hg IOP reduction from the baseline without addition of new antiglaucoma medications). No adverse effects associated with PASCAL laser peripheral iridoplasty were observed.
Conclusions
PASCAL laser iridoplasty can be a safe and effective alternative to argon laser peripheral iridoplasty in the management of eyes with plateau iris syndrome. Our findings need to be further validated on larger sample size and in different ethnicities.
MeSH Terms
Shields Classification
Key Concepts5
PASCAL laser peripheral iridoplasty resulted in angle widening in 46% of treated quadrants by at least 1 grade (Shaffer classification) at 1-month follow-up in eyes with plateau iris syndrome.
PASCAL laser peripheral iridoplasty achieved a statistically significant intraocular pressure (IOP) reduction at 1 year from 20.6±4.8 to 17.8±3.8 mm Hg (P=0.01) in eyes with plateau iris syndrome.
At 1 month, 8 of 12 eyes (66.6%) treated with PASCAL laser peripheral iridoplasty achieved gonioscopic success (widening of the angle by at least 1 grade in 2 of 4 quadrants) in eyes with plateau iris syndrome.
At 1 year, 6 of 12 eyes (50%) treated with PASCAL laser peripheral iridoplasty achieved tonometric success (20% reduction or 3 mm Hg IOP reduction from the baseline without addition of new antiglaucoma medications) in eyes with plateau iris syndrome.
No adverse effects associated with PASCAL laser peripheral iridoplasty were observed in eyes with plateau iris syndrome.
Related Articles5
Laser peripheral iridotomy in primary angle-closure suspects: biometric and gonioscopic outcomes: the Liwan Eye Study.
Cohort StudyLow iris and anterior chamber volume is associated with deepening after laser peripheral iridotomy in primary angle closure suspects.
Case SeriesThe changing geometry of angle closure.
Observational StudyAnterior Segment Dimensions Following Laser Iridotomy in Acute Primary Angle Closure and Fellow Eyes.
Case SeriesInvestigation of laser peripheral iridotomy characteristics using the ImageJ program on anterior segment parameters.
Retrospective StudyIs this article assigned to the wrong chapter(s)? Let us know.